Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo

Kenneth C. Haltalin, John D. Nelson, Robert Ring, Mildred Sladoje, Lula V. Hinton

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

A double-blind treatment study comparing ampicillin, sulfadiazine, and placebo was performed in 52 infants and children hospitalized for shigellosis. Bacteriological failure rates in patients treated with placebo and sulfadiazine were 75 per cent and 39 per cent, respectively, compared with 6 per cent in ampicillin-treated patients. Clinical failure occurred in 56 per cent of patients treated with placebo, 39 per cent in sulfadiazine-treated patients and in none of the patients who received ampicillin. Ampicillin is a safe and highly effective drug for the treatment of shigellosis.

Original languageEnglish (US)
Pages (from-to)970-981
Number of pages12
JournalThe Journal of Pediatrics
Volume70
Issue number6
StatePublished - Jun 1967

Fingerprint

Sulfadiazine
Bacillary Dysentery
Ampicillin
Double-Blind Method
Placebos
Therapeutics
Hospitalized Child
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo. / Haltalin, Kenneth C.; Nelson, John D.; Ring, Robert; Sladoje, Mildred; Hinton, Lula V.

In: The Journal of Pediatrics, Vol. 70, No. 6, 06.1967, p. 970-981.

Research output: Contribution to journalArticle

Haltalin, KC, Nelson, JD, Ring, R, Sladoje, M & Hinton, LV 1967, 'Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo', The Journal of Pediatrics, vol. 70, no. 6, pp. 970-981.
Haltalin, Kenneth C. ; Nelson, John D. ; Ring, Robert ; Sladoje, Mildred ; Hinton, Lula V. / Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo. In: The Journal of Pediatrics. 1967 ; Vol. 70, No. 6. pp. 970-981.
@article{539585b848394d4cb4395a79ff5ca4c2,
title = "Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo",
abstract = "A double-blind treatment study comparing ampicillin, sulfadiazine, and placebo was performed in 52 infants and children hospitalized for shigellosis. Bacteriological failure rates in patients treated with placebo and sulfadiazine were 75 per cent and 39 per cent, respectively, compared with 6 per cent in ampicillin-treated patients. Clinical failure occurred in 56 per cent of patients treated with placebo, 39 per cent in sulfadiazine-treated patients and in none of the patients who received ampicillin. Ampicillin is a safe and highly effective drug for the treatment of shigellosis.",
author = "Haltalin, {Kenneth C.} and Nelson, {John D.} and Robert Ring and Mildred Sladoje and Hinton, {Lula V.}",
year = "1967",
month = "6",
language = "English (US)",
volume = "70",
pages = "970--981",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo

AU - Haltalin, Kenneth C.

AU - Nelson, John D.

AU - Ring, Robert

AU - Sladoje, Mildred

AU - Hinton, Lula V.

PY - 1967/6

Y1 - 1967/6

N2 - A double-blind treatment study comparing ampicillin, sulfadiazine, and placebo was performed in 52 infants and children hospitalized for shigellosis. Bacteriological failure rates in patients treated with placebo and sulfadiazine were 75 per cent and 39 per cent, respectively, compared with 6 per cent in ampicillin-treated patients. Clinical failure occurred in 56 per cent of patients treated with placebo, 39 per cent in sulfadiazine-treated patients and in none of the patients who received ampicillin. Ampicillin is a safe and highly effective drug for the treatment of shigellosis.

AB - A double-blind treatment study comparing ampicillin, sulfadiazine, and placebo was performed in 52 infants and children hospitalized for shigellosis. Bacteriological failure rates in patients treated with placebo and sulfadiazine were 75 per cent and 39 per cent, respectively, compared with 6 per cent in ampicillin-treated patients. Clinical failure occurred in 56 per cent of patients treated with placebo, 39 per cent in sulfadiazine-treated patients and in none of the patients who received ampicillin. Ampicillin is a safe and highly effective drug for the treatment of shigellosis.

UR - http://www.scopus.com/inward/record.url?scp=0014093470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0014093470&partnerID=8YFLogxK

M3 - Article

C2 - 5338090

AN - SCOPUS:0014093470

VL - 70

SP - 970

EP - 981

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 6

ER -